65 related articles for article (PubMed ID: 22320884)
1. MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma.
Yu Y; Zhang Y; Hu J; Zhang H; Wang S; Han F; Yue L; Qu Y; Zhang Y; Liang H; Nie H; Li Y
Cancer Sci; 2012 Apr; 103(4):716-22. PubMed ID: 22320884
[TBL] [Abstract][Full Text] [Related]
2. MARVELD1 regulates integrin β1-mediated cell adhesion and actin organization via inhibiting its pre-mRNA processing.
Wang S; Hu J; Yao Y; Shi M; Yue L; Han F; Zhang H; He J; Liu S; Li Y
Int J Biochem Cell Biol; 2013 Nov; 45(11):2679-87. PubMed ID: 24055813
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a novel gene, c1orf109, encoding a CK2 substrate that is involved in cancer cell proliferation.
Liu SS; Zheng HX; Jiang HD; He J; Yu Y; Qu YP; Yue L; Zhang Y; Li Y
J Biomed Sci; 2012 May; 19(1):49. PubMed ID: 22548824
[TBL] [Abstract][Full Text] [Related]
4. MARVELD1 modulates cell surface morphology and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
Yao Y; Shi M; Liu S; Li Y; Guo K; Ci Y; Liu W; Li Y
Mol Carcinog; 2016 Nov; 55(11):1714-1727. PubMed ID: 26509557
[TBL] [Abstract][Full Text] [Related]
5. A clinical prognostic model of oxidative stress-related genes linked to tumor immune cell infiltration and the prognosis of ovarian cancer patients.
Li L; Zhang W; Sun Y; Zhang W; Lu M; Wang J; Jin Y; Xi Q
Heliyon; 2024 Apr; 10(7):e28442. PubMed ID: 38560253
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic modifications inhibit the expression of MARVELD1 and in turn tumorigenesis by regulating the Wnt/β-catenin pathway in pan-cancer.
Zhang J; Li Q; Sun Q; Wang B; Cui Y; Lou C; Yao Y; Zhang Y
J Cancer; 2022; 13(1):225-242. PubMed ID: 34976185
[TBL] [Abstract][Full Text] [Related]
7. Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma.
Song ZB; Yu Y; Zhang GP; Li SQ
Front Cell Dev Biol; 2021; 9():728574. PubMed ID: 34676211
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.
Xia L; Jin P; Tian W; Liang S; Tan L; Li B
Braz J Med Biol Res; 2021; 54(7):e10236. PubMed ID: 34008750
[TBL] [Abstract][Full Text] [Related]
9. MARVELD1 attenuates arsenic trioxide-induced apoptosis in liver cancer cells by inhibiting reactive oxygen species production.
Ma W; Shen H; Li Q; Song H; Guo Y; Li F; Zhou X; Guo X; Shi J; Cui Q; Xing J; Deng J; Yu Y; Liu W; Zhao H
Ann Transl Med; 2019 May; 7(9):200. PubMed ID: 31205918
[TBL] [Abstract][Full Text] [Related]
10. The Role of Toll-Like Receptors in Oncotherapy.
Liu C; Han C; Liu J
Oncol Res; 2019 Aug; 27(8):965-978. PubMed ID: 30940297
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells.
Li J; Yan H; Zhao L; Jia W; Yang H; Liu L; Zhou X; Miao P; Sun X; Song S; Zhao X; Liu J; Huang G
Oncotarget; 2016 Aug; 7(32):52392-52403. PubMed ID: 27447558
[TBL] [Abstract][Full Text] [Related]
12. Application potential of toll-like receptors in cancer immunotherapy: Systematic review.
Shi M; Chen X; Ye K; Yao Y; Li Y
Medicine (Baltimore); 2016 Jun; 95(25):e3951. PubMed ID: 27336891
[TBL] [Abstract][Full Text] [Related]
13. Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.
Nie H; Liu X; Zhang Y; Li T; Zhan C; Huo W; He A; Yao Y; Jin Y; Qu Y; Sun XL; Li Y
Sci Rep; 2015 Nov; 5():16007. PubMed ID: 26537865
[TBL] [Abstract][Full Text] [Related]
14. Biological and clinical significance of epigenetic silencing of MARVELD1 gene in lung cancer.
Shi M; Wang S; Yao Y; Li Y; Zhang H; Han F; Nie H; Su J; Wang Z; Yue L; Cao J; Li Y
Sci Rep; 2014 Dec; 4():7545. PubMed ID: 25520033
[TBL] [Abstract][Full Text] [Related]
15. MAP1S controls breast cancer cell TLR5 signaling pathway and promotes TLR5 signaling-based tumor suppression.
Shi M; Yao Y; Han F; Li Y; Li Y
PLoS One; 2014; 9(1):e86839. PubMed ID: 24466264
[TBL] [Abstract][Full Text] [Related]
16. VX680 suppresses the growth of HepG2 cells and enhances the chemosensitivity to cisplatin.
Yao R; Zheng J; Zheng W; Gong Y; Liu W; Xing R
Oncol Lett; 2014 Jan; 7(1):121-124. PubMed ID: 24348832
[TBL] [Abstract][Full Text] [Related]
17. MARVELD1 Inhibits Nonsense-Mediated RNA Decay by Repressing Serine Phosphorylation of UPF1.
Hu J; Li Y; Li P
PLoS One; 2013; 8(6):e68291. PubMed ID: 23826386
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
